Keith is a valued member of a team committed to advancing Precision Medicine in Oncology and Reproductive Health. Currently, he oversees ThermoFisher’s Clinical Microarray portfolio in the Middle East, Israel, Africa, and Turkey. Keith’s primary focus involves emphasizing the importance of Omics technologies. His mission includes identifying suitable embryos for implantation, empowering clinics to implement targeted genetic testing in oncology, advancing pre/postnatal cytogenetics testing for IDD/ASD, and providing consultation on the implementation of nationwide carrier screening programs.

Keith Qassab